Levomilnacipran-based drug for functional recovery after acute neurological events
AssigneePierre Fabre Medicament
InventorPierre Sokoloff
Life of this patent
Estimating the term…
Abstract
The present invention concerns the use of levomilnacipran as medicinal product in functional recovery after a cerebrovascular accident or traumatic brain injury. The pharmaceutical compositions containing levomilnacipran are exclusively those not containing dextromilnacipran to a proportion of more than 5% by weight of the levomilnacipran/dextromilnacipran mixture, to avoid compromising functional recovery due to the alpha1-blocking property of dextromilnacipran.
Claims8
A levomilnacipran/dextromilnacipran mixture containing dextromilnacipran in a proportion not exceeding 5% by weight of the said mixture for use thereof as medicinal product for recovery and functional rehabilitation after an acute neurological event and recurrences thereof.
Pharmaceutical compositions comprising at least one pharmaceutically acceptable excipient and a levomilnacipran/dextromilnacipran mixture containing dextromilnacipran in a proportion not exceeding 5% by weight of the said mixture as active ingredient for use thereof as medicinal product for recovery and functional rehabilitation after an acute neurological event and recurrences thereof.
Dependencies are inferred from the claim text.